Cathie Wood at ArK values a company as the risk adjusted NPV of future cashflows. On that basis TLG could easily be valued at usd10Bn.
Often there is a discount against Scoping or PFS NPV for execution risk. Although they have used 8% cost of capital which is excessive.
TLG is under the radar, undervalued and the management team clearly understand the situation.
All hold large positions. I fully expect a very substantial rerate this year. To quote MT, "the next 6 to 12 months will be the most transformative in the history of the business"
When I expect TLG to trade at a premium to its NPV.
- Forums
- ASX - By Stock
- TLG
- TLG - Media
TLG - Media, page-937
-
- There are more pages in this discussion • 15,242 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLG (ASX) to my watchlist
(20min delay)
|
|||||
Last
55.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $207.9M |
Open | High | Low | Value | Volume |
56.0¢ | 56.5¢ | 54.0¢ | $243.9K | 441.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 16578 | 55.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
56.5¢ | 16509 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 16578 | 0.555 |
10 | 46131 | 0.550 |
7 | 20173 | 0.545 |
10 | 33178 | 0.540 |
5 | 34797 | 0.535 |
Price($) | Vol. | No. |
---|---|---|
0.565 | 16509 | 12 |
0.570 | 70573 | 10 |
0.575 | 1249 | 1 |
0.580 | 52219 | 4 |
0.585 | 33748 | 3 |
Last trade - 14.07pm 15/07/2024 (20 minute delay) ? |
Featured News
TLG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online